Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study (Q42909983)
Jump to navigation
Jump to search
scientific article published on September 8, 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study |
scientific article published on September 8, 2010 |
Statements
1 reference
Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study (English)
1 reference
1 reference
G. Comi
O. Abramsky
T. Arbizu
A. Boyko
R. Gold
E. Havrdová
S. Komoly
K. Selmaj
B. Sharrack
8 September 2010
1 reference
1 reference
16
1 reference
11
1 reference
1360-1366
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference